10/08/2026
At Team Jack, we believe awareness is important, but research is what moves us closer to better treatments and, ultimately, cures for kids with brain cancer.
In 2024, we committed $575,000 to the University of Colorado Anschutz to support the research of Sujatha Venkataraman, PhD. The goal of her project is to advance a new, targeted CAR T cell therapy that were developed by her team for children with deadly brain tumors such as DIPG, a cancer with no effective treatments and almost no long-term survivors.
“With support from the Team Jack Foundation, the team has made major progress. This funding has dramatically accelerated the science and helped remove key barriers on the path toward FDA approval,” said Dr. Venkataraman.
If successful, this therapy could help improve survival and quality of life for children with brain cancer while reducing long-term side effects.
This video gives a glimpse into the research made possible because of YOU, our donors, supporters and families, who believe that children with brain cancer deserve better. Please take a few minutes to watch:
YouTube https://youtu.be/cwSp6_JcyqI
Dr. Sujatha Venkataraman shares and update on her "gated" CAR-T cel...